The Bonebridge implant in older children and adolescents with mixed or conductive hearing loss: Audiological outcomes.


Journal

International journal of pediatric otorhinolaryngology
ISSN: 1872-8464
Titre abrégé: Int J Pediatr Otorhinolaryngol
Pays: Ireland
ID NLM: 8003603

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 24 07 2018
revised: 17 12 2018
accepted: 19 12 2018
pubmed: 2 1 2019
medline: 16 3 2019
entrez: 2 1 2019
Statut: ppublish

Résumé

For children with conductive or mixed hearing loss, in whom use of conventional hearing aids is impossible or limited, use of bone conduction devices is recommended. The choice between the available types of devices depends mostly on the degree of hearing loss, age, and anatomical conditions. One device application in children older than 5 years is the Bonebridge implant. The aim of this study is to assess the benefits and safety of this device in children. The material was a group of 11 older children and adolescents aged 10-17 years (mean = 14.7, SD = 2.45) with single-sided or bilateral conductive or mixed hearing loss, implanted unilaterally with the Bonebridge system at the World Hearing Center in Kajetany near Warsaw between 2014 and 2016. Benefits of the Bonebridge were assessed with warble tone audiometry and word audiometry in free field, as well as an APHAB (Abbreviated Profile of Hearing Aid Benefit) questionnaire before and after implantation. Hearing tests showed a statistically significant improvement in hearing sensitivity and speech discrimination. Results of the questionnaire confirm the benefits of Bonebridge implantation to the older children in terms of their auditory performance under various acoustic conditions. At a one-year follow up the Bonebridge system was found to be a safe, efficient, and effective tool for compensating for conductive or mixed hearing loss in older children and adolescents. For good anatomical conditions the Bonebridge implant provides a safe alternative to other popular bone conduction systems.

Identifiants

pubmed: 30599287
pii: S0165-5876(18)30637-2
doi: 10.1016/j.ijporl.2018.12.026
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

97-102

Informations de copyright

Copyright © 2018 Elsevier B.V. All rights reserved.

Auteurs

Anna Ratuszniak (A)

Institute of Physiology and Pathology of Hearing, World Hearing Center, Otorhinolaryngology Surgery Clinic, Mokra 17 Str., 05-830, Kajetany, Poland. Electronic address: a.ratuszniak@ifps.org.pl.

Piotr Henryk Skarzynski (PH)

Institute of Sensory Organs, Kajetany, Mokra 1 Str., 05-830, Kajetany, Poland; Heart Failure and Cardiac Rehabilitation Department, Second Faculty, Medical University of Warsaw, Banacha 1a, 02-097, Warsaw, Poland; Institute of Physiology and Pathology of Hearing, World Hearing Center, Teleaudiology Department, Mokra 17 Str., 05-830, Kajetany, Poland.

Elzbieta Gos (E)

Institute of Physiology and Pathology of Hearing, World Hearing Center, Teleaudiology Department, Mokra 17 Str., 05-830, Kajetany, Poland.

Henryk Skarzynski (H)

Institute of Physiology and Pathology of Hearing, World Hearing Center, Otorhinolaryngology Surgery Clinic, Mokra 17 Str., 05-830, Kajetany, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH